Quoin Pharmaceuticals, Ltd. (QNRX), Tuesday announced the pricing of offering of around 4.1 million shares, representing same amount of American Depository Shares or ADS, and warrants, at a combined price of $1.6 per share, to raise approximately $6.5 million.
The specialty pharmaceutical company intends to use the proceeds for corporate-related purposes.
The company stated that the warrants, Series D and Series E, would be exercisable immediately following the date of issuance and would expire in two years and five years, respectively, from their issuance.
The offering is expected to close on or about March 7.
Following the announcement, Quoin's stock is currently tumbling 44.48 percent, to $1.57 over the previous close of $2.9 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.